MedTrace Logo

Assessing The Treatment Effect in Metabolic Syndrome Without Perceptible diabeTes (ATTEMPT)

NCT00416741 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2011-06-27

No results posted yet for this study

Summary

The objective of this protocol is to improve awareness, treatment, and control of metabolic syndrome, within primary prevention of cardiovascular disease, by implementing guidelines, after training of the participating physicians.

Conditions

  • Metabolic Syndrome

Interventions

BEHAVIORAL

Implementation of guidelines

Attaining targets for LDL cholesterol, arterial blood pressure, fasting \[plasma flucose

Sponsors & Collaborators

  • Hellenic Atherosclerosis Society

    lead OTHER

Principal Investigators

  • Vasilios G Athyros, MD · Clinical Trials Chair of Hellenic Atherosclerosis Society

  • Moses - Elisaf, MD · Clinical Trials Director of Hellenic Atherosclerosis Society

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-02-28
Primary Completion
2011-01-31
Completion
2011-02-28

Countries

  • Greece

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00416741 on ClinicalTrials.gov